Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes Care 29:571-574, 2006
DOI: 10.2337/diacare.29.03.06.dc05-2009
© 2006 by the American Diabetes Association
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weissman, A.
Right arrow Articles by Zimmer, E. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weissman, A.
Right arrow Articles by Zimmer, E. Z.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Power Spectral Analysis of Heart Rate Variability During the 100-g Oral Glucose Tolerance Test in Pregnant Women

Amir Weissman, MD1, Lior Lowenstein, MD1, Amir Peleg, MD1, Israel Thaler, MD1,2 and Etan Z. Zimmer, MD1,2

1 Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
2 Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Address correspondencereprint requests to Amir Weissman, MD, Department of ObstetricsGynecology, Rambam Medical Center, POB 9602, Haifa, 31096, Israel. E-mail: wamir{at}netvision.net.il


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 References
 
OBJECTIVE—The aims of the present study were to 1) evaluate autonomic function during the oral glucose tolerance test (OGTT) in pregnant women and 2) investigate whether gestational diabetes mellitus (GDM) modifies autonomic control of heart rate variability.

RESEARCH DESIGN AND METHODS—We prospectively studied 27 pregnant women (15 without GDM, 12 with GDM) during a 100-g OGTT. The maternal electrocardiogram was recorded before and 60 min after glucose ingestion, when peak glucose levels are expected. The time and frequency domains of maternal cardiac intervals were analyzed.

RESULTS—There was a significant decrease in the high-frequency (HF) band in both groups after the ingestion of glucose. The normalized low-frequency (LF) band significantly increased and the normalized HF band significantly decreased after glucose ingestion. The LF-to-HF ratio was significantly higher in the group with GDM at baseline and significantly increased in both groups after glucose ingestion. A regression analysis revealed a significant decrease in the HF band with increasing blood glucose levels.

CONCLUSIONS—Acute elevation of blood glucose levels during the OGTT caused substantial autonomic alterations, including sympathetic activation and parasympathetic withdrawal. Both arms of the autonomic system were affected during the test, thus lending support to the concept that these changes are centrally integrated. The autonomic changes were less pronounced in women with GDM compared with in normal control subjects, suggesting that chronic hyperglycemia and hyperinsulinemia may alter modulation of the autonomic nervous system.

Abbreviations: ECG, electrocardiogram • GDM, gestational diabetes mellitus • HF, high frequency • LF, low frequency • OGTT, oral glucose tolerance test • VLF, very low frequency


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 References
 
Glucose ingestion has been shown to alter the activity of the autonomic nervous system (1–2). Cardiovascular autonomic function and baroreflex sensitivity are inversely related to blood glucose levels in healthy individuals (3–5). During pregnancy, there are significant physiological alterations in glucose absorption and metabolism that cause an increase in insulin resistance. In addition, profound hemodynamic changes take place, with an increase in cardiac output and a decrease in total peripheral resistance accompanied by an expanded blood volume (6). During the 100-g oral glucose tolerance test (OGTT), performed in pregnant women for the diagnosis of gestational diabetes mellitus (GDM), blood glucose levels are increased within a short time period. These abrupt changes in blood glucose may cause maternal and fetal metabolic and cardiovascular alterations (7–9).

Heart rate variability, modulated by diverse central and peripheral inputs, provides a quantitative marker of autonomic activity. Spectral analysis of heart rate variability is an accepted method for assessing the autonomic nervous system and permits a noninvasive evaluation of the sensitivity of the sinoatrial node to sympathetic and parasympathetic activity (10–11).

The aims of the present study were to 1) evaluate the effects of rapid changes in blood glucose levels during the 100-g OGTT in pregnant women on heart rate variability and 2) investigate whether women diagnosed with GDM react differently to the OGTT compared with euglycemic women.


   RESEARCH DESIGN AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
RESULTS
 CONCLUSIONS
 References
 
For this study, 27 healthy, nonsmoking women with normal pregnancies between 24–28 weeks gestation were recruited. All had an abnormal 1-h 50-g glucose challenge test (≥140 mg/dl [≥7.8 mmol/l]) and were therefore referred for the 100-g OGTT. None had hypertension, thyroid disease, obesity, or a family history of diabetes. The study was approved by the Institutional Review Board in accordance with the Helsinki Declaration, and each patient signed an informed consent.

The 100-g OGTT was performed between 8:00 and 9:00 A.M. after the subjects had fasted overnight for least 8 h. In the 3 preceding days, all women followed an unrestricted diet containing at least 150 g of carbohydrates. After giving a fasting venous blood sample, the women were asked to drink a solution of 100 g of glucose dissolved in 200 ml of water within 10 min. Blood samples were then obtained at 60, 120, and 180 min. Plasma glucose levels were determined by the glucose oxidase method (Hitachi 747). All patients were studied in the supine position. An electrocardiogram (ECG) via bipolar skin electrodes was performed for 10 min before the glucose tolerance test (phase 0) and was repeated at 60 min after glucose ingestion, when peak glucose levels were expected (phase 1). The diagnosis of GDM was established when two or more of the following venous plasma glucose levels were exceeded: fasting, 5.8 mmol/l; 1 h, 10.6 mmol/l; 2 h, 9.2 mmol/l; or 3 h, 8.1 mmol/l (12).

ECG data processing
The ECG was digitized at 200 samples/s using a 12-bit analog-to-digital converter and stored in a binary format for subsequent analysis. Peak R wave detection was performed using a derivative/amplitude criterion algorithm. The power spectrum of the interbeat intervals was obtained by an autoregressive model, applying an order of 16. Three frequency bands were defined: the very low frequency (VLF) band (<0.03 Hz), related mainly to thermoregulation; the low-frequency (LF) band (0.03–0.15 Hz), related mainly to baroreflex control of arterial blood pressure and modulated by the parasympathetic and sympathetic arms of the autonomic nervous system; and the high-frequency (HF) band (0.15–0.40 Hz), primarily attributed to respiratory sinus arrhythmia and modulated by the parasympathetic system. The area under the respective frequency bands was integrated and expressed in absolute units. Total power (TP) and the LF-to-HF ratio, regarded as an index of sympathovagal balance, were also computed. The LF and HF bands were expressed in normalized units (LF normalized units = LF/[TP – VLF]; HF normalized units = HF/[TP – VLF]). When expressed in normalized units, LF is considered to be a quantitative index of sympathetic activity (10). Time domain measures (heart rate, mean normal-to-normal interval, the standard deviation of all RR intervals, the square root of the mean squared differences between RR intervals, and the standard deviation of successive differences between RR intervals) were also computed.

Statistical analyses
Statistical computations were performed using Statgraphics 5 software (Manugistics, San Carlos, CA). A two-way ANOVA was applied to test differences between patients with and without GDM at the two phases of the study (GDM x phase). Regression analyses were performed to assess the relation between blood glucose levels and the different variables studied. P < 0.05 was considered statistically significant. Results are given as means ± SD. Power calculations performed before the initiation of the study indicated that to detect true differences with 80% power at a two-sided significance level of 5% and with the different variables we included in the analyses, a sample size of 14 participants would be adequate.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
CONCLUSIONS
 References
 
The characteristics of the two study populations are given in Table 1. Women in both groups were of a similar age and had a similar weight and BMI. Their fasting plasma glucose levels differed significantly and were significantly higher in the women who were subsequently diagnosed as having GDM; however, they did not differ by the results of the 1-h 50-g glucose challenge test. Variables derived by analysis in the time and frequency domains in both groups (i.e., with and without GDM) are presented in Table 2. There were no statistically significant changes in the time domain measures between the two groups in the different phases of the study. There was a decrease in the LF and HF bands in both groups after the ingestion of glucose; however, only the change in the HF band reached statistical significance. The magnitude of this decrease was similar in both groups.


View this table:
[in this window]
[in a new window]
  		Table 1— Baseline characteristics of the study groups

 

View this table:
[in this window]
[in a new window]
  		Table 2— Glucose levels and time and frequency domain measures in women with and without GDM

 
The normalized LF band significantly increased and the normalized HF band significantly decreased after glucose ingestion. The two-way ANOVA revealed that these differences were significantly related to the ingestion of the glucose solution (defining the phase) but were unaffected by the presence of GDM. The LF-to-HF ratio was significantly higher in the GDM group at baseline (phase 0) compared with in the euglycemic group, and it significantly increased in both groups after glucose ingestion. It was still substantially higher in the GDM group in phase 1.

Linear regression analyses revealed a significant decrease in the HF band with increasing blood glucose levels (P < 0.02, correlation coefficient –0.317, R2 = 10.1%) (Fig. 1). The equation of the fitted model is Y = 165.6 – (0.425 x HF), where Y is glucose level.


Figure 1
View larger version (13K):
[in this window]
[in a new window]
  		Figure 1— HF band in relation to blood glucose levels.

 

   CONCLUSIONS
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
References
 
The present study showed that an acute glucose load during an OGTT in pregnant women induces significant changes in the autonomic control of heart rate variability. The changes are characterized by sympathetic dominance and an attenuation of parasympathetic activity. A negative correlation between blood glucose levels and parasympathetic activity, represented by the HF band (both in absolute and normalized units), was demonstrated, and an increase in the LF-to-HF ratio after the glucose load was also observed. This was particularly striking in the non-GDM group, thus emphasizing the effect of acute hyperglycemia in normal pregnant women. However, the LF-to-HF ratio, a measure of sympathovagal balance, was significantly higher in women with GDM in the fasting state and after glucose ingestion, thereby implicating the influence of chronic hyperglycemia on the autonomic nervous system (Table 2). The decrease in spectral density was more prominent in the HF band, which is a marker of vagal activity (13). The observed changes suggest that women with GDM have an increased sympathetic activation at baseline compared with non-GDM women and that the sympathetic balance is further shifted after glucose ingestion. This supports the concept that women with GDM are more insulin resistant and have higher baseline glucose and insulin levels. It has been previously reported that impaired autonomic control of heart rate occurs early in diabetes (14) and that even modest elevations of fasting plasma glucose or insulin can impair autonomic cardiac control (4). Our study demonstrated that impaired autonomic control of heart rate variability also occurs in pregnant women who are diagnosed with GDM.

Only a small number of studies on the effect of induced hyperglycemia on the autonomic nervous system in nonpregnant healthy subjects have been published, and data for pregnant women are even more scarce (15). Paolisso and colleagues (1–2) reported that glucose ingestion alters cardiac autonomic functions in healthy, nonpregnant patients and that the LF-to-HF ratio correlates with the amount of body fat. In our study, the BMI did not significantly differ between the two groups, suggesting that the increase in the LF-to-HF ratio probably reflects acutely elevated blood glucose levels. Indeed, the LF-to-HF ratio has also been reported to increase after a 75-g OGTT in healthy older subjects (2). It appears that an acute glucose load universally modifies the modulation of heart rate variability by the autonomic nervous system.

During a 100-g OGTT, a rapid increase in blood glucose levels occurs within a relatively short time, and an increase in insulin secretion rapidly follows. In healthy humans, insulin levels rise shortly after food intake in accordance with the rise in plasma glucose, and the increase is directly proportional to the quantity of carbohydrate ingested (16–17). Acute hyperglycemia also causes systemic hemodynamic changes in healthy and type 2 diabetic subjects; this effect is independent of endogenous insulin secretion as it persists even when insulin excretion is suppressed (18–19). These changes consist of an increase in heart rate and blood pressure, suggesting a vasoconstrictive effect due to alterations in baroreflex activity. Insulin itself exerts a potent vasodilator effect that has been reported to stimulate sympathetic activity (20). These autonomic and hemodynamic alterations become even more complex in pregnancy, during which substantial cardiovascular and hemodynamic changes normally occur.

During pregnancy, an increase in insulin resistance normally occurs, and it even becomes more striking in women with GDM (21). Whether the effects of glucose on the autonomic nervous system are direct or mediated by plasma insulin has yet to be determined. Several studies support the role of insulin rather than plasma glucose in mediating the stimulatory effects on the sympathetic nervous system after a glucose load (22–24). Others hypothesize that hyperglycemia may increase the production of free radicals that mediate the hemodynamic effects (19).

In summary, acute short-term elevations of blood glucose during the OGTT in pregnant women are associated with sympathetic activation and parasympathetic withdrawal. The observation that both arms of the autonomic system are reciprocally affected supports the concept that these changes are centrally integrated. Chronic exposure to higher blood glucose and insulin levels, as are seen in pregnant women with GDM, may amplify the changes observed in the autonomic control over maternal heart rate variability.


   Footnotes
 
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received for publication October 19, 2005. Accepted for publication December 12, 2005.


   References
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 References
 

  1. Paolisso G, Manzella D, Ferrara N, Gambardella A, Abete P, Tagliamonte MR, De Lucia D, Furgi G, Picone C, Gentile S, Rengo F, Varricchio M: Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat. Am J Physiol 273:E471–E478, 1997
  2. Paolisso G, Manzella D, Rizzo MR, Barbieri M, Gambardella A, Varricchio M: Effects of glucose ingestion on cardiac autonomic nervous system in healthy centenarians: differences with aged subjects. Euro J Clin Invest 30:277–284, 2000[Medline]
  3. Marfella R, Nappo F, De Angelis L, Siniscalchi M, Rossi F, Giugliano D: The effect of acute hyperglycemia on QTc duration in healthy man. Diabetologia 43:571–575, 2000[Medline]
  4. Watkins LL, Surwit RS, Grossman P, Sherwood A: Is there a glycemic threshold for impaired autonomic control? Diabetes Care 23:826–830, 2000[Abstract/Free Full Text]
  5. Lefrandt JD, Mulder MC, Bosma E, Smit AJ, Hoogenberg K: Inverse relationship between blood glucose and autonomic function in healthy subjects. Diabetes Care 23:1862–1863, 2000[Free Full Text]
  6. Cunningham FG, Gant NF, Leveno KJ, Gilstap LC III, Hauth JC, Wenstrom KD (Eds.): Maternal adaptations to pregnancy. In Williams Obstetrics, 21st ed. New York, McGraw-Hill, 2001, p. 167–200
  7. Bocking A, Adamson L, Carmichael L, Patrick J, Probert C: Effect of intravenous glucose injection on human maternal and fetal heart rate at term. Am J Obstet Gynecol 148:414–420, 1984[Medline]
  8. Yeap BB, Russo A, Fraser RJ, Wittert GA, Horowitz M: Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care 19:880–882, 1996[Abstract]
  9. Weissman A, Goldshtick O, Geva A, Zimmer EZ: Computerized analysis of fetal heart rate indices during oral glucose tolerance test. J Perinat Med 31:302–306, 2003[Medline]
  10. Task Force of the European Society of Cardiology and North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurements, physiological interpretation and clinical use. Circulation 93:1043–1065, 1996[Free Full Text]
  11. Eckberg DL: Sympathovagal balance: a critical appraisal. Circulation 96:3224–3232, 1997[Free Full Text]
  12. Metzger BE, Coustan DR: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl. 2):B161–B167, 1998
  13. Bellavere F, Cacciatori V, Moghetti P, Gemma ML, Dellera A, Tosi F, Negri C, Thomaseth K, Muggeo M: Acute effect of insulin on autonomic regulation of the cardiovascular system: a study by heart rate spectral analysis. Diabet Med 13:709–714, 1996[Medline]
  14. Leitinen J, Uusitupa M, Siitonen O, Pyörälä K: Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 38:1307–1313, 1989[Abstract]
  15. Airaksinen KE, Salmela PI, Ikaheimo MJ, Kirkinen P, Linnaluoto MK, Takkunen JT: Effect of pregnancy on autonomic nervous function and heart rate in diabetic and nondiabetic women. Diabetes Care 10:748–751, 1987[Abstract]
  16. Tillil H, Shapiro ET, Miller MA, Karrison T, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS: Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol 254:E349–E357, 1988
  17. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W: Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492–498, 1986[Abstract]
  18. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, Ceriello A, Giugliano D: Glutathione reverses systemic hemodynamic changes induced by hyperglycemia in healthy subjects. Am J Physiol 268:E1167–E1173, 1995
  19. Marfella R, Nappo F, De Angelis L, Paolisso G, Tagliamonte MR, Giugliano D: Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care 23:658–663, 2000[Abstract/Free Full Text]
  20. Baron AD: Hemodynamic actions of insulin. Am J Physiol 267:E187–E202, 1994
  21. Bowes SB, Hennessy TR, Umpelby AM, Benn JJ, Jackson NC, Boroujerdi MA, Sonksen PH, Lowy C: Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia 39:976–983, 1996[Medline]
  22. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 30:219–225, 1981[Medline]
  23. Vollenweider P, Tappy L, Randin D, Schneiter P, Jequier E, Nicod P, Scherrer U: Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92:147–154, 1994
  24. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U: Impaired insulin-induced sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive man. Blood Press 3:394–403, 1994[Medline]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
S-S. Chiou and C-D. Kuo
Effect of chewing a single betel-quid on autonomic nervous modulation in healthy young adults
J Psychopharmacol, November 1, 2008; 22(8): 910 - 917.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
J. H. O'Keefe, N. M. Gheewala, and J. O. O'Keefe
Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health
J. Am. Coll. Cardiol., January 22, 2008; 51(3): 249 - 255.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weissman, A.
Right arrow Articles by Zimmer, E. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weissman, A.
Right arrow Articles by Zimmer, E. Z.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum